Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Downey

Showing results (151-160 of 185) with videos related to

Pageof 19
Sort By:
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 4, 2020
Safety and efficacy of lenabasum in a phase 2 randomized, placebo-controlled trial in adults with cystic fibrosisJames F Chmiel, Patrick Flume, Damian G Downey, et al.
International Journal of Antimicrobial Agents|September 24, 2014
Do veterinary antibiotics have efficacy against highly resistant Gram-negative pathogens from patients with cystic fibrosis?John E Moore, Michael Alcorn, Wakana Ara, et al.
European Journal of Clinical Pharmacology|July 29, 2014
Ascertainment of acute liver injury in two European primary care databasesA Ruigómez, R Brauer, L A García Rodríguez, et al.
Clinical Microbiology Reviews|August 19, 2024
Practical Guidance for Clinical Microbiology Laboratories: Updated guidance for processing respiratory tract samples from people with cystic fibrosisLisa Saiman, Valerie Waters, John J LiPuma, et al.
ERJ Open Research|October 30, 2020
Inhaled dry powder alginate oligosaccharide in cystic fibrosis: a randomised, double-blind, placebo-controlled, crossover phase 2b studySilke van Koningsbruggen-Rietschel, Jane C Davies, Tacjana Pressler, et al.
Anti-Cancer Drugs|August 1, 1997
An update of a phase II study of paclitaxel in advanced or recurrent squamous cell cancer of the cervixA P Kudelka, R Winn, C L Edwards, et al.
Nature|December 17, 2025
Titan's strong tidal dissipation precludes a subsurface oceanFlavio Petricca, Steven D Vance, Marzia Parisi, et al.
Journal of Clinical Microbiology|June 8, 2018
"Pathogen Eradication" and "Emerging Pathogens": Difficult Definitions in Cystic FibrosisPeter H Gilligan, Damian G Downey, J Stuart Elborn, et al.
The Lancet. Respiratory Medicine|September 12, 2023
Understanding and addressing the needs of people with cystic fibrosis in the era of CFTR modulator therapyKatherine B Hisert, Susan E Birket, John Paul Clancy, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 26, 2019
Assessment of stability and fluctuations of cultured lower airway bacterial communities in people with cystic fibrosisLaura J Sherrard, Gisli G Einarsson, Elinor Johnston, et al.
Pageof 19

Showing results (151-160 of 185) with videos related to

Sort By:
Pageof 19
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 4, 2020
Safety and efficacy of lenabasum in a phase 2 randomized, placebo-controlled trial in adults with cystic fibrosisJames F Chmiel, Patrick Flume, Damian G Downey, et al.
International Journal of Antimicrobial Agents|September 24, 2014
Do veterinary antibiotics have efficacy against highly resistant Gram-negative pathogens from patients with cystic fibrosis?John E Moore, Michael Alcorn, Wakana Ara, et al.
European Journal of Clinical Pharmacology|July 29, 2014
Ascertainment of acute liver injury in two European primary care databasesA Ruigómez, R Brauer, L A García Rodríguez, et al.
Clinical Microbiology Reviews|August 19, 2024
Practical Guidance for Clinical Microbiology Laboratories: Updated guidance for processing respiratory tract samples from people with cystic fibrosisLisa Saiman, Valerie Waters, John J LiPuma, et al.
ERJ Open Research|October 30, 2020
Inhaled dry powder alginate oligosaccharide in cystic fibrosis: a randomised, double-blind, placebo-controlled, crossover phase 2b studySilke van Koningsbruggen-Rietschel, Jane C Davies, Tacjana Pressler, et al.
Anti-Cancer Drugs|August 1, 1997
An update of a phase II study of paclitaxel in advanced or recurrent squamous cell cancer of the cervixA P Kudelka, R Winn, C L Edwards, et al.
Nature|December 17, 2025
Titan's strong tidal dissipation precludes a subsurface oceanFlavio Petricca, Steven D Vance, Marzia Parisi, et al.
Journal of Clinical Microbiology|June 8, 2018
"Pathogen Eradication" and "Emerging Pathogens": Difficult Definitions in Cystic FibrosisPeter H Gilligan, Damian G Downey, J Stuart Elborn, et al.
The Lancet. Respiratory Medicine|September 12, 2023
Understanding and addressing the needs of people with cystic fibrosis in the era of CFTR modulator therapyKatherine B Hisert, Susan E Birket, John Paul Clancy, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 26, 2019
Assessment of stability and fluctuations of cultured lower airway bacterial communities in people with cystic fibrosisLaura J Sherrard, Gisli G Einarsson, Elinor Johnston, et al.
Pageof 19